المؤلفون: V. Sciannameo (10778798), P. Berchialla (10778801), A. Avogaro (10778804), G. P. Fadini (10778807)

مصطلحات موضوعية: Medicine, Biotechnology, Computational Biology, Biological Sciences not elsewhere classified, CVOT stratum-specific effects, EMPA-REG, DPP -4 inhibitors, TECOS, 2D, DECLARE, stratum-specific treatment effects, LEADER, SUSTAIN, type 2 diabetes, outcome trial effects, MACE, PIONEER -6, target population, post-stratification HR estimate, EXSCEL, type 2 diabetes Abstract Background.

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Transposition_of_cardiovascular_outcome_trial_effects_to_the_real-world_population_of_patients_with_type_2_diabetes/14570234

الاتاحة: https://doi.org/10.6084/m9.figshare.14570234.v1

المؤلفون: Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group

المصدر: Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-13 (2017)

مصطلحات موضوعية: Cardiovascular risk, Diabetes, CVOT, DEVOTE, CANVAS program, EXSCEL, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12933-017-0610-y; https://doaj.org/toc/1475-2840

URL الوصول: https://doaj.org/article/4aaccee354444ec0a72fba5419a1c384

المؤلفون: Mentz, RJ, Bethel, MA, Merrill, P, Lokhnygina, Y, Buse, JB, Chan, JC, Felício, JS, Goodman, SG, Choi, J, Gustavson, SM, Iqbal, N, Lopes, RD, Maggioni, AP, Öhman, P, Pagidipati, NJ, Poulter, NR, Ramachandran, A, Reicher, B, Holman, RR, Hernandez, AF, EXSCEL Study Group

مصطلحات موضوعية: glucagon‐like peptide‐1 receptor agonis, major adverse cardiac event, mortality, type 2 diabetes mellitus, EXSCEL Study Group

جغرافية الموضوع: England

Relation: Journal of the American Heart Association; http://hdl.handle.net/10044/1/65163; https://dx.doi.org/10.1161/JAHA.118.009304

الاتاحة: http://hdl.handle.net/10044/1/65163
https://doi.org/10.1161/JAHA.118.009304

المؤلفون: Bethel, MA, Patel, RA, Merrill, P, Lokhnygina, Y, Buse, JB, Mentz, RJ, Pagidipati, NJ, Chan, JC, Gustavson, SM, Iqbal, N, Maggioni, AP, Ohman, P, Poulter, NR, Ramachandran, A, Zinman, B, Hernandez, AF, Holman, RR

المصدر: 113 ; 105

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Endocrinology & Metabolism, DIPEPTIDYL PEPTIDASE-4 INHIBITORS, OPEN-LABEL, EXENATIDE, LIXISENATIDE, LIRAGLUTIDE, EXSCEL Study Group

Relation: LANCET DIABETES & ENDOCRINOLOGY; http://hdl.handle.net/10044/1/61644; https://dx.doi.org/10.1016/S2213-8587(17)30412-6

الاتاحة: http://hdl.handle.net/10044/1/61644
https://doi.org/10.1016/S2213-8587(17)30412-6

المؤلفون: Grigg, Robert D

المصدر: Lynchburg Journal of Medical Science

مصطلحات موضوعية: CANVAS, DECLARE-TIMI-58, EMPAG-REV-Outcome, EXSCEL, LEADER, SUSTAIN-6, canagliflozin, empagliflozin, dapagliflozin, exenatide, liraglutide, and semaglutide, Major Adverse Cardiovascular Events (MACE), Endocrine System Diseases, Endocrinology, Diabetes, and Metabolism, Family Medicine, Medical Pharmacology, Other Pharmacy and Pharmaceutical Sciences

وصف الملف: application/pdf

Relation: https://digitalshowcase.lynchburg.edu/dmscjournal/vol4/iss2/31; https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=2201&context=dmscjournal

الاتاحة: https://digitalshowcase.lynchburg.edu/dmscjournal/vol4/iss2/31
https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=2201&context=dmscjournal

المؤلفون: Mentz, Robert J, Bethel, M Angelyn, Merrill, Peter, Lokhnygina, Yuliya, Buse, John B, Chan, Juliana C, Felício, João S, Goodman, Shaun G, Choi, Jasmine, Gustavson, Stephanie M, Iqbal, Nayyar, Lopes, Renato D, Maggioni, Aldo P, Öhman, Peter, Pagidipati, Neha J, Poulter, Neil R, Ramachandran, Ambady, Reicher, Barry, Holman, Rury R, Hernandez, Adrian F, EXSCEL Study Group

مصطلحات موضوعية: EXSCEL Study Group, Humans, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Treatment Outcome, Drug Administration Schedule, Incidence, Cause of Death, Survival Rate, Risk Assessment, Risk Factors, Retrospective Studies, Follow-Up Studies, Dose-Response Relationship, Drug, Time Factors, Aged, Middle Aged, United States, Female, Male, Glycated Hemoglobin A, Exenatide

وصف الملف: application/pdf

Relation: Journal of the American Heart Association; https://hdl.handle.net/10161/19763

الاتاحة: https://hdl.handle.net/10161/19763

المؤلفون: João S. Felício, Peter Merrill, M. Angelyn Bethel, Stephanie M. Gustavson, Ambady Ramachandran, Rury R. Holman, Jasmine Choi, Renato D. Lopes, Aldo P. Maggioni, Juliana C.N. Chan, Yuliya Lokhnygina, Neil R Poulter, Barry Reicher, Robert J. Mentz, Nayyar Iqbal, Neha J. Pagidipati, Adrian F. Hernandez, John B. Buse, Shaun G. Goodman, Peter Öhman

المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

مصطلحات موضوعية: Male, Time Factors, type 2 diabetes mellitus, EXSCEL Study Group, 030204 cardiovascular system & hematology, 0302 clinical medicine, Risk Factors, Cause of Death, Cardiovascular Disease, 030212 general & internal medicine, Original Research, Cause of death, 2. Zero hunger, Incidence, Incidence (epidemiology), Diabetes, Type 2, Middle Aged, 3. Good health, Survival Rate, Treatment Outcome, Cardiovascular Diseases, Female, Mortality/Survival, Cardiology and Cardiovascular Medicine, Risk assessment, medicine.drug, medicine.medical_specialty, Risk Assessment, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, medicine, Humans, Hypoglycemic Agents, In patient, Survival rate, Aged, Retrospective Studies, Glycated Hemoglobin, Dose-Response Relationship, Drug, Kidney in Cardiovascular Disease, business.industry, Type 2 Diabetes Mellitus, Retrospective cohort study, glucagon‐like peptide‐1 receptor agonis, mortality, United States, Diabetes Mellitus, Type 2, major adverse cardiac event, Exenatide, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd55d9417213f47709a7ecba80fb98f
http://hdl.handle.net/10044/1/65163

المؤلفون: Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Stefano Genovese, Nebojsa Lalic, Katarina Lalic, Jan Skrha, Paul Valensi, Antonio Ceriello

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-6 (2018)

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, DEVOTE, CANVAS program, Endocrinology, Diabetes and Metabolism, D&CVD EASD Study Group, Diabetes, CVOT Summit, EXSCEL, 030204 cardiovascular system & hematology, Cardiovascular risk, 3. Good health, CVOT, 03 medical and health sciences, 0302 clinical medicine, lcsh:RC666-701, Commentary, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, ACE

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a2d17dc813e709f5c820dececa935e
https://doi.org/10.1186/s12933-018-0667-2

المؤلفون: Juliana C.N. Chan, Neil Poulter, Neha J. Pagidipati, Ambady Ramachandran, Rishi A Patel, Nayyar Iqbal, M. Angelyn Bethel, Aldo P. Maggioni, John B. Buse, Robert J. Mentz, Stephanie M. Gustavson, Peter Öhman, Peter Merrill, Yuliya Lokhnygina, Bernard Zinman, Rury R. Holman, Adrian F. Hernandez

مصطلحات موضوعية: Relative risk reduction, medicine.medical_specialty, EXENATIDE, EXSCEL Study Group, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Cardiovascular System, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, Endocrinology & Metabolism, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Stroke, LIXISENATIDE, Science & Technology, Liraglutide, business.industry, Semaglutide, Odds ratio, medicine.disease, Prognosis, OPEN-LABEL, Survival Rate, chemistry, Diabetes Mellitus, Type 2, Cardiovascular Diseases, LIRAGLUTIDE, business, Exenatide, Life Sciences & Biomedicine, medicine.drug, DIPEPTIDYL PEPTIDASE-4 INHIBITORS

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512ea14ac3164d176b6632c4b4a4bf74
http://hdl.handle.net/10044/1/61644

المؤلفون: Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group

المصدر: Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-4 (2017)
Cardiovascular Diabetology

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, MEDLINE, Alternative medicine, 030209 endocrinology & metabolism, Review, 030204 cardiovascular system & hematology, Outcome (game theory), Glucagon-Like Peptide-1 Receptor, CVOT, 03 medical and health sciences, 0302 clinical medicine, Sodium-Glucose Transporter 2, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Intensive care medicine, Sodium-Glucose Transporter 2 Inhibitors, ACE, Angiology, Clinical Trials as Topic, Dipeptidyl-Peptidase IV Inhibitors, DEVOTE, CANVAS program, business.industry, Published Erratum, Diabetes, EXSCEL, Correction, Heart, Cardiovascular risk, medicine.disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, Cardiology, Cardiology and Cardiovascular Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1cbaf90f32bed516bb20062b4052baa
https://doi.org/10.1186/s12933-017-0633-4

المؤلفون: Holman, Rury R., Bethel, Angelyn, Mentz, Robert J., Thompson, Vivian P., Lokhnygina, Yuliya, Buse, John B., Chan, Juliana C., Choi, Jasmine, Gustavson,, Stephanie M., Iqbal, Nayyar, Maggioni, Aldo P., Marso, Steven P., Öhman, Peter, Pagidipat, Neha J., Poulter, Neil, Ramachandran, Ambady, Zinman, Bernard, Hernandez, Adrian F.

المساهمون: Barsienė, Lina, Šulskienė, M., Varanauskienė, Eglė, Danytė, Evalda, Urbanavičienė, Elena, Urbanavičius, Vaidotas, Zabulienė, Lina, Juškienė, Rasa, Vėlavičienė, A., Kakariekienė, V., Augustėnienė, Audronė, Veličkienė, Džilda, Lašienė, Jūratė, Daukšienė, D., Čaponis, J.

المصدر: New England journal of medicine, Waltham : Massachusetts Medical Society, 2017, Vol. 377, Iss. 13, p. 1228-1239 ; ISSN 0028-4793 ; eISSN 1533-4406

مصطلحات موضوعية: event lowering exscel, glucose control, risk

Relation: http://vu.lvb.lt/VU:ELABAPDB24954450&prefLang=en_US

الاتاحة: http://vu.lvb.lt/VU:ELABAPDB24954450&prefLang=en_US

المؤلفون: Holman, RR, Bethel, MA, Mentz, RJ, Thompson, VP, Lokhnygina, Y, Buse, JB, Chan, JC, Choi, J, Gustavson, SM, Iqbal, N, Maggioni, AP, Marso, SP, Öhman, P, Pagidipati, NJ, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, AF, EXSCEL Study Group

المصدر: 1239 ; 1228

مصطلحات موضوعية: Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Drug Administration Schedule, Female, Humans, Hypoglycemic Agents, Incidence, Injections, Subcutaneous, Kaplan-Meier Estimate, Least-Squares Analysis, Male, Middle Aged, Peptides, Venoms, EXSCEL Study Group

جغرافية الموضوع: United States

Relation: New England Journal of Medicine; http://hdl.handle.net/10044/1/61283; https://dx.doi.org/10.1056/NEJMoa1612917

الاتاحة: http://hdl.handle.net/10044/1/61283
https://doi.org/10.1056/NEJMoa1612917